Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paganelli

Showing results (161-170 of 165) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 165 results.
Ecancermedicalscience|January 26, 2012
IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotinG Paganelli, C De Cicco, M E Ferrari, et al.
Physics in Medicine and Biology|November 9, 2013
Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT imagesF Botta, A Mairani, R F Hobbs, et al.
British Journal of Cancer|April 3, 2003
Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT)R De Santis, A M Anastasi, V D'Alessio, et al.
Ecancermedicalscience|January 26, 2012
Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of OncologyR Biffi, F Orsi, M G Zampino, et al.
Scientific Reports|March 21, 2014
A novel radioguided surgery technique exploiting β(-) decaysE Solfaroli Camillocci, G Baroni, F Bellini, et al.
Pageof 17

Showing results (161-170 of 165) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 165 results.
Ecancermedicalscience|January 26, 2012
IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotinG Paganelli, C De Cicco, M E Ferrari, et al.
Physics in Medicine and Biology|November 9, 2013
Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT imagesF Botta, A Mairani, R F Hobbs, et al.
British Journal of Cancer|April 3, 2003
Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT)R De Santis, A M Anastasi, V D'Alessio, et al.
Ecancermedicalscience|January 26, 2012
Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of OncologyR Biffi, F Orsi, M G Zampino, et al.
Scientific Reports|March 21, 2014
A novel radioguided surgery technique exploiting β(-) decaysE Solfaroli Camillocci, G Baroni, F Bellini, et al.
Pageof 17